The Chicago Cubs have bolstered their pitching rotation for the 2026 season by acquiring Kevin Gausman from the Toronto Blue Jays and Clay Holmes from the New York Mets. Gausman, a veteran right-hander known for his playoff experience, was acquired in exchange for prospects Ty Southisene and Brett Bateman. Meanwhile, Holmes, who was on the 60-day injured list due to a fractured right fibula, joins Chicago pending a medical review. These strategic moves are part of the Cubs’ ongoing efforts to enhance their rotation depth, which has been built around pitchers like Matthew Boyd and Shota Imanaga.
Key Takeaways
- The Cubs’ acquisition of Gausman and Holmes appears consistent with a strategic move to strengthen their rotation.
- The Cubs’ moves suggest a long-term strategy to compete strongly in the 2026 season.
- The addition of these pitchers could indirectly impact competition in the NL East, potentially affecting teams like the Atlanta Braves.
What to Watch
The completion of Holmes’ medical review may indicate whether his move to the Cubs is finalized. Additionally, how these acquisitions impact the Cubs’ performance and the broader dynamics of the National League will be of interest. Developments in the Braves’ performance and any further activity by NL East teams could also influence outcomes.